Shadia Zaman is a Product Quality Team Lead in the Office of Biotechnology Products in the Center for Drug Evaluation and Research (CDER) at FDA. Her work involves evaluating the chemistry, manufacturing, and control of drug applications for biologics. Prior to working as an assessor, Dr. Zaman was a Commissioner’s Fellow in the Office of Clinical Pharmacology at CDER, FDA where she worked on building a systems pharmacology model on predicting drug-associated cardiotoxicity. Dr. Zaman also completed a postdoctoral fellowship at National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health on endocrine tumors and a postdoctoral fellowship at University of Texas MD Anderson Cancer Center on hematologic malignancies, where she eventually became a junior research faculty.